Answers are grounded in this paper and cite their sources.
Observes QT-interval prolongation in cardio-oncology, highlighting a novel drug effect.
As the field of cardio-oncology evolves, it has become apparent that many of the novel therapies are associated with QT-interval prolongation. The combination of the physical properties of the drugs themselves, in addition to the clinical symptoms of nausea, vomiting, and diarrhea that cause electrolyte abnormalities, and the medications to treat those symptoms, may all contribute to prolongation of the QT interval.1
No takes yet. Share an insight, caveat, or question.
Teng et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: